Colin Dollery

British pharmacologist (1931–2020)

Sir Colin Terence Dollery (14 March 1931 – 12 December 2020) was a clinical pharmacologist who spent much of his life working for SmithKline Beecham and its successor, Glaxo Smith Kline.[1][2] He was knighted in the Queen's 1987 birthday honours.[3] He was an honorary fellow of the British Pharmacological Society[4] and a fellow of the Academy of Medical Sciences.[5]

Biography

After graduating in medicine from the University of Birmingham in 1956, Dollery specialized in clinical pharmacology. He was appointed as a lecturer in therapeutics at the Royal Postgraduate Medical School, London, in 1963, being promoted to Professor of Clinical Pharmacology in 1968.[6] During his career he was:[6]

  • Founding Chairman of the Clinical Pharmacology Section of the British Pharmacological Society (1975–1975)
  • Chair of the Clinical Section of the International Union of Pharmacology (IUPHAR; 1975–1978)
  • President of the IUPHAR (1987–1990).

He received many awards including the Wellcome Gold Medal awarded by the British Pharmacological Society. His work led to major advances in cardiovascular pharmacology including work with the Nobel Laureate, Sir James Black concerning beta blockers. Dollery spent time in both academia and industry (SmithKline Beecham and then GSK post the merger). He was also active within IUPHAR, where he was part of the clinical translational pharmacology group of the Nomenclature Committee.

His fields of interest included hypertension and drug safety.

In 1993 he gave the Harveian Oration.

Books

Books authored or edited include:

  • Dollery, Colin T. (1978). The end of an age of optimism : medical science in retrospect and prospect. London: Nuffield Provincial Hospitals Trust. ISBN 0900574291.
  • Dollery, Colin (1999). Therapeutic drugs (2nd ed.). Edinburgh: Churchill Livingstone. ISBN 0443051488.
  • Dollery, Colin; Williams, John, eds. (1996). Informatics in undergraduate medical and dental curricula. London: Royal Society of Medicine. ISBN 1853152846.

References

  1. ^ Spedding, Michael. "Sir Colin Dollery" (PDF). IUPHAR.
  2. ^ "Birthdays". The Times. 14 March 2003.
  3. ^ St James's Palace (12 June 1987). "Central Chancery of the orders of knighthood". London Gazette.
  4. ^ "Sir Colin Dollery". British Pharmacological Society.
  5. ^ "Deceased Fellows | The Academy of Medical Sciences". acmedsci.ac.uk.
  6. ^ a b George, CF; Paterson, JW (September 1996). "Festschrift in honour of Professor Sir Colin Dollery". Trends in Pharmacological Sciences. 17 (9): 317–8. doi:10.1016/0165-6147(96)30017-5. PMID 8885696.

Further reading

  • Sir Colin Dollery: Life and Work on YouTube, a video biography compiled by the British Pharmacological Society
  • Dollery, Colin T. (June 2006). "Clinical pharmacology - the first 75 years and a view of the future". British Journal of Clinical Pharmacology. 61 (6): 650–665. doi:10.1111/j.1365-2125.2006.02672.x. PMC 1885127.
  • Dollery, CT (May 2014). "Lost in Translation (LiT): IUPHAR Review 6". British Journal of Pharmacology. 171 (9): 2269–90. doi:10.1111/bph.12580. PMC 3997269. PMID 24428732.

External links

  • Linkedin profile
Authority control databases: Academics Edit this at Wikidata
  • ORCID